Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cuevas

Showing results (161-170 of 163) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 163 results.
Medical and Pediatric Oncology|October 23, 1997
Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in childrenA M Silván, M J Gordillo, A M Lopez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotenceI S de Tejada, D S Garvey, J D Schroeder, et al.
EMBO Molecular Medicine|July 7, 2011
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomasGema Moreno-Bueno, Fernando Salvador, Alberto Martín, et al.
Pageof 17

Showing results (161-170 of 163) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 163 results.
Medical and Pediatric Oncology|October 23, 1997
Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in childrenA M Silván, M J Gordillo, A M Lopez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotenceI S de Tejada, D S Garvey, J D Schroeder, et al.
EMBO Molecular Medicine|July 7, 2011
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomasGema Moreno-Bueno, Fernando Salvador, Alberto Martín, et al.
Pageof 17